ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 3647

$392K Total Retail Price of All Prescriptions

Rank: 1542 out of 3647

547 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 14,794 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

11% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$21 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,462 1,206 1 1
LISINOPRIL 699 573 2 4
FUROSEMIDE 637 561 3 8
LEVOTHYROXINE SODIUM 557 477 4 5
METFORMIN HCL 535 411 5 6
AMLODIPINE BESYLATE 527 428 6 2
TRAMADOL HCL 490 363 7 22
HYDROCODONE-ACETAMINOPHEN 488 300 S3 8 12
CARVEDILOL 471 407 9 20
METOPROLOL TARTRATE 452 406 10 7
PRAVASTATIN SODIUM 444 376 11 16
BENAZEPRIL-HYDROCHLOROTHIAZIDE 375 322 10 12 270
HYDROCHLOROTHIAZIDE 300 256 13 9
ALPRAZOLAM 295 291 14 31
RANITIDINE HCL 281 225 15 29
BENAZEPRIL HCL 281 229 15 71
FAMOTIDINE 240 219 17 61
GABAPENTIN 234 134 18 17
ALENDRONATE SODIUM 230 230 19 23
CITALOPRAM HBR 226 193 20 25
OMEPRAZOLE 223 169 21 3
ALLOPURINOL 207 143 22 37
PREDNISONE 205 160 23 43
POTASSIUM CHLORIDE 202 183 24 24
MECLIZINE HCL 194 185 25 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 193 151 26 36
BACLOFEN 177 102 27 97
GLIMEPIRIDE 168 128 28 45
ZOLPIDEM TARTRATE 160 125 29 14
ISOSORBIDE MONONITRATE ER 149 135 30 56
ATENOLOL 141 137 31 10
LOSARTAN POTASSIUM 140 103 32 11
CAPTOPRIL 137 114 33 193
DOXAZOSIN MESYLATE 136 121 34 57
NORTRIPTYLINE HCL 136 104 34 273
NIFEDIPINE ER 134 128 36 67
LOSARTAN-HYDROCHLOROTHIAZIDE 132 114 37 48
PANTOPRAZOLE SODIUM 130 79 38 38
GLIPIZIDE 129 112 39 41
WARFARIN SODIUM 126 99 40 15
NOVOLIN 70-30 125 88 41 130
TRIAMTERENE-HCTZ 121 111 42 58
KLOR-CON 10 120 115 43 106
TRAZODONE HCL 119 78 44 64
INSULIN SYRINGE 118 92 45 76
PROAIR HFA 109 78 46 62
TRIAMCINOLONE ACETONIDE 103 81 47 136
SERTRALINE HCL 99 60 48 27
CLOPIDOGREL 98 88 49 26
CLONIDINE HCL 97 88 50 46
ATORVASTATIN CALCIUM 94 94 51 13
LACTULOSE 92 70 52 128
MELOXICAM 84 65 53 33
GLYBURIDE 83 83 R 54 54
HUMULIN 70-30 82 63 55 192
PROPRANOLOL HCL 77 46 56 156
SALSALATE 77 56 56 605
NAPROXEN 77 68 56 70
FLUOXETINE HCL 74 41 59 68
FINASTERIDE 71 68 60 66
PLAVIX 68 62 61 39
VERAPAMIL ER 66 63 62 99
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 49 62 110
DOXYCYCLINE HYCLATE 64 39 64 145
TRIAMTERENE-HYDROCHLOROTHIAZID 63 63 65 223
METFORMIN HCL ER 60 48 66 92
ENALAPRIL MALEATE 59 48 67 35
SPIRONOLACTONE 58 31 68 77
RISPERIDONE 58 24 68 83
OXYCODONE-ACETAMINOPHEN 56 50 S2 70 91
METHADONE HCL 56 25 S2 70 174
BUSPIRONE HCL 54 33 72 162
PHENYTOIN SODIUM EXTENDED 53 25 73 199
DILTIAZEM 24HR CD 53 42 73 155
PAROXETINE HCL 53 37 73 60
DILTIAZEM ER 52 46 76 167
NIFEDICAL XL 52 39 76 221
GLIPIZIDE ER 51 49 78 112
VENTOLIN HFA 50 39 79 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.